{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:16:15Z","timestamp":1783617375856,"version":"3.55.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sichuan Provincial Hospital Association Young Pharmacists Research Fund Project","award":["YP2202437"],"award-info":[{"award-number":["YP2202437"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Severe community-acquired pneumonia (sCAP) is a serious respiratory disease that often requires urgent and comprehensive treatment. The use of glucocorticoids for the treatment of sCAP has been a focus of discussion in the medical community because of their potential benefits and safety concerns. A literature review showed that the benefits of glucocorticoids in the treatment of sCAP may be related to factors such as oxygenation index, high CRP levels, shock, non-influenza, female gender, early application, and hydrocortisone. The application of glucocorticoids in the treatment of sCAP needs to be considered on an individual basis, weighing the potential benefits and risks, and monitoring and preventing possible side effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049670","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:00:08Z","timestamp":1783098008000},"page":"e49670","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive analysis of factors to consider when using glucocorticoids for sCAP: A review"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7756-5374","authenticated-orcid":false,"given":"Tingrui","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mianyang people\u2019s Hospital, Mianyang, Sichuan, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4482-4220","authenticated-orcid":false,"given":"Jisheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260709","doi-asserted-by":"crossref","first-page":"220123","DOI":"10.1183\/16000617.0123-2022","article-title":"Severe community-acquired pneumonia.","volume":"31","author":"Niederman","year":"2022","journal-title":"Eur Respir Rev"},{"key":"R2-20260709","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia.","volume":"49","author":"Martin-Loeches","year":"2023","journal-title":"Intensive Care Med"},{"key":"R3-20260709","first-page":"D7720","article-title":"Corticosteroids for pneumonia.","volume":"2017","author":"Stern","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-20260709","first-page":"101253","article-title":"Steroids in severe community-acquired pneumonia: dangerous, worthless, or miracle cure? The roller coaster of clinical trials.","volume":"42","author":"Bouras","year":"2023","journal-title":"Anaesth Crit Care Pain Med"},{"key":"R5-20260709","doi-asserted-by":"crossref","first-page":"1135228","DOI":"10.3389\/fcimb.2023.1135228","article-title":"Clinical features and \u201cearly\u201d corticosteroid treatment outcome of pediatric mycoplasma pneumoniae pneumonia.","volume":"13","author":"Liu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R6-20260709","doi-asserted-by":"crossref","first-page":"104284","DOI":"10.1016\/j.ebiom.2022.104284","article-title":"The hypothalamus-pituitary-adrenal axis in sepsis- and hyperinflammation-induced critical illness: Gaps in current knowledge and future translational research directions.","volume":"84","author":"Van den Berghe","year":"2022","journal-title":"EBioMedicine"},{"key":"R7-20260709","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3389\/fimmu.2018.01736","article-title":"Immune effects of corticosteroids in sepsis.","volume":"9","author":"Heming","year":"2018","journal-title":"Front Immunol"},{"key":"R8-20260709","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fendo.2016.00070","article-title":"The role of ACTH and corticosteroids for sepsis and septic shock: an update.","volume":"7","author":"Annane","year":"2016","journal-title":"Front Endocrinol"},{"key":"R9-20260709","doi-asserted-by":"crossref","first-page":"1473151","DOI":"10.3389\/fendo.2024.1473151","article-title":"Critical illness-related corticosteroid insufficiency (CIRCI) - an overview of pathogenesis, clinical presentation and management.","volume":"15","author":"Sobolewska","year":"2024","journal-title":"Front Endocrinol"},{"key":"R10-20260709","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","article-title":"Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial.","volume":"181","author":"Snijders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20260709","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1183\/09031936.00191709","article-title":"Adrenal function is related to prognosis in moderate community-acquired pneumonia.","volume":"36","author":"Kolditz","year":"2010","journal-title":"Eur Respir J"},{"key":"R12-20260709","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/bmj.38181.482222.55","article-title":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis.","volume":"329","author":"Annane","year":"2004","journal-title":"BMJ"},{"key":"R13-20260709","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jcrc.2010.03.004","article-title":"Cortisol levels and adrenal response in severe community-acquired pneumonia: a systematic review of the literature.","volume":"25","author":"Salluh","year":"2010","journal-title":"J Crit Care"},{"key":"R14-20260709","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"R15-20260709","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2017.10.010","article-title":"Therapeutic mechanisms of glucocorticoids.","volume":"29","author":"Vandewalle","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"R16-20260709","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4187\/respcare.06314","article-title":"Clinical pharmacology of corticosteroids.","volume":"63","author":"Williams","year":"2018","journal-title":"Respir Care"},{"key":"R17-20260709","doi-asserted-by":"crossref","first-page":"e2300105","DOI":"10.1056\/EVIDe2300105","article-title":"The evolving understanding of glucocorticoid treatment in septic shock.","volume":"2","author":"Hibbert","year":"2023","journal-title":"NEJM Evid"},{"key":"R18-20260709","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12871-023-02131-y","article-title":"Association between short-term systemic use of glucocorticoids and prognosis of cardiogenic shock: a retrospective analysis.","volume":"23","author":"Fan","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"R19-20260709","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","article-title":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis.","volume":"179","author":"Fang","year":"2019","journal-title":"JAMA Intern Med"},{"key":"R20-20260709","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/endrev\/bnad016","article-title":"Treating the side effects of exogenous glucocorticoids; can we separate the good from the bad?","volume":"44","author":"Pofi","year":"2023","journal-title":"Endocr Rev"},{"key":"R21-20260709","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0889-8529(18)30091-4","article-title":"Glucocorticoids and infection.","volume":"23","author":"Aucott","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R22-20260709","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America.","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-20260709","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","article-title":"2024 focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia.","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Crit Care Med"},{"key":"R24-20260709","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","article-title":"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia.","volume":"48","author":"Meduri","year":"2022","journal-title":"Intensive Care Med"},{"key":"R25-20260709","first-page":"671","article-title":"Hydrocortisone in severe community-acquired pneumonia. Reply.","volume":"389","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"key":"R26-20260709","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMe2302544","article-title":"Time to treat severe community-acquired pneumonia with steroids?","volume":"388","author":"Metlay","year":"2023","journal-title":"N Engl J Med"},{"key":"R27-20260709","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"key":"R29-20260709","doi-asserted-by":"crossref","first-page":"2102532","DOI":"10.1183\/13993003.02532-2021","article-title":"Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support.","volume":"60","author":"Crothers","year":"2022","journal-title":"Eur Respir J"},{"key":"R30-20260709","doi-asserted-by":"crossref","first-page":"678260","DOI":"10.3389\/fmed.2021.678260","article-title":"The role of glucocorticoids in the treatment of ARDS: a multicenter retrospective study based on the eICU collaborative research database.","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R31-20260709","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1513\/AnnalsATS.202208-720OC","article-title":"Higher- versus lower-dose corticosteroids for severe to critical COVID-19: a systematic review and dose-response meta-analysis.","volume":"20","author":"Pitre","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"R32-20260709","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1001\/jama.2021.18295","article-title":"Effect of 12\u2009mg vs 6\u2009mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial.","volume":"326","author":"Munch","year":"2021","journal-title":"JAMA"},{"key":"R33-20260709","doi-asserted-by":"crossref","first-page":"e002141","DOI":"10.1136\/bmjresp-2023-002141","article-title":"Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis.","volume":"11","author":"See","year":"2024","journal-title":"BMJ Open Respir Res"},{"key":"R34-20260709","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/cid\/ciad762","article-title":"Corticosteroids demonstrate efficacy solely in severe cases of community-acquired pneumonia, with hydrocortisone showing notable effectiveness.","volume":"78","author":"Li","year":"2024","journal-title":"Clin Infect Dis"},{"key":"R35-20260709","doi-asserted-by":"crossref","first-page":"1479804","DOI":"10.3389\/fphar.2024.1479804","article-title":"Association between various types of corticosteroids and mortality for severe community-acquired pneumonia in adults: a systematic review and network meta-analysis.","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"R36-20260709","doi-asserted-by":"crossref","first-page":"1457469","DOI":"10.3389\/fmed.2024.1457469","article-title":"The effect and safety of corticosteroid treatment for severe community-acquired pneumonia: a meta-analysis of randomized controlled trials.","volume":"11","author":"Chen","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R37-20260709","doi-asserted-by":"crossref","first-page":"T35","DOI":"10.1530\/JOE-16-0669","article-title":"30 years of the mineralocorticoid receptor: mineralocorticoid receptor and NaCl transport mechanisms in the renal distal nephron.","volume":"234","author":"Shibata","year":"2017","journal-title":"J Endocrinol"},{"key":"R38-20260709","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1007\/s00134-020-06289-8","article-title":"Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS.","volume":"46","author":"Meduri","year":"2020","journal-title":"Intensive Care Med"},{"key":"R39-20260709","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial.","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet"},{"key":"R40-20260709","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.","volume":"377","author":"Meijvis","year":"2011","journal-title":"Lancet"},{"key":"R41-20260709","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:02:23Z","timestamp":1783616543000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":40,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049670","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"2024-12-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}